Nir Skalka Email & Phone Number
Who is Nir Skalka? Overview
A concise factual answer block for searchers comparing this professional profile.
Nir Skalka is listed as Chief Scientific Officer (CSO), and acting CEO at Circuit-Bio LTD, based in Israel, Israel, Israel. AeroLeads shows a matched LinkedIn profile for Nir Skalka.
Nir Skalka previously worked as Head of Immuno-oncology team at Aummune Ltd and Scientist at Augmanity. Nir Skalka holds Doctor Of Philosophy (Phd), Biochemistry And Molecular Biology from Tel Aviv University.
Email format at Circuit-Bio LTD
This section adds company-level context without repeating Nir Skalka's masked contact details.
Review company-level records connected to Nir Skalka before choosing the right outreach path.
About Nir Skalka
CSO and acting CEO of Circuit-Bio LTD.Circuit-Bio is a pre-clinical synthetic biology company developing an innovative unique platform of logical gene circuits for cancer immunotherapy.https://circuitbiotech.com/
Listed skills include Western Blotting, Biochemistry, Molecular Biology, Tissue Culture, and 22 others.
Nir Skalka's current company
Company context helps verify the profile and gives searchers a useful next step.
Nir Skalka work experience
A career timeline built from the work history available for this profile.
Head Of Immuno-Oncology Team
Scientist
R&D
Research and Development at Diabest Co. Drug development based on medicinal plants. The research includes characterization of active ingredients, developing methods of testing drug efficacy, working with cell cultures, RT-PCR and mice preclinical development. Some of the work includes writing reports, training, teaching and leading the project.
Phd Student
- Colorectal cancer and the Wnt signal: Research aimed to Identify new Wnt signal components by using a new genetic functional screen. I identified the enzyme carboxypeptidase E (CPE) and its splice variant, N-CPE, as.
- Mass Spectrometry – Immunoprecipitation of complexes for identification of new interaction with CPE in mammalian cells. Identify two protein interactions that are now under investigation.
- Gene therapy: Research aimed to find new genetic manipulations against cancer cells and tumors based on tumor specific gene expression (working with "Nude" mice). The research is in its final stage, the results will be.
- Drugs treatment: Researched the ability of several drugs to downregulate the Wnt signal. Min-/+ mice were Treated with drugs and their small and large intestine were examined for polypes. Among other aspects I examined.
- APC mutation polymorphism: Polyps from colon cancer patiens were examined for APC allele mutations polymorphism.
- Aminoglycosides derivates: Examining the half-life and the treatment of new Aminoglycoside derivates on C57BL/6 and Min-/+ mice colorectal cancer.
Team Leader And Project Management.
- 2010–2014. Team leader, project management and training of graduate and master students - training includes management of research, guidance and teaching methods.
- 2008–2014. Participation in writing articles, reports and submitting grants.
M.Sc Student
- Pharmaceutical products biochemistry and sol-gel chromatography: Focus on the development of immunochemical methods for monitoring environmental pollutants and drug residues in food, environmental and biological.
- PCBs ELISA combined with sol-gel chromatography: Development of an immunoassay and a sol-gel-based immunoaffinity cleanup method for coplanar polychlorinated biphenyls from soil and sediment samples.
- Orientations: Extensive work with sol-gel-based immunoaffinity purification (IAP) chromatography, LC/MS/MS, SPE columns. Development polyclonal antibodies in rabbits aimed against NSAIDs drugs (Indomethacin and.
B.Sc. In Biology
Nir Skalka education
Doctor Of Philosophy (Phd), Biochemistry And Molecular Biology
Master'S Degree, Biochemistry
Bachelor Of Applied Science (B.A.Sc.), Biology/Biological Sciences, General
Frequently asked questions about Nir Skalka
Quick answers generated from the profile data available on this page.
What company does Nir Skalka work for?
Nir Skalka works for Circuit-Bio LTD.
What is Nir Skalka's role at Circuit-Bio LTD?
Nir Skalka is listed as Chief Scientific Officer (CSO), and acting CEO at Circuit-Bio LTD.
Where is Nir Skalka based?
Nir Skalka is based in Israel, Israel, Israel while working with Circuit-Bio LTD.
What companies has Nir Skalka worked for?
Nir Skalka has worked for Circuit-Bio Ltd, Aummune Ltd, Augmanity, Diabest Botanical Drugs, and Tel-Aviv University.
How can I contact Nir Skalka?
You can use AeroLeads to view verified contact signals for Nir Skalka at Circuit-Bio LTD, including work email, phone, and LinkedIn data when available.
What schools did Nir Skalka attend?
Nir Skalka holds Doctor Of Philosophy (Phd), Biochemistry And Molecular Biology from Tel Aviv University.
What skills is Nir Skalka known for?
Nir Skalka is listed with skills including Western Blotting, Biochemistry, Molecular Biology, Tissue Culture, Pcr, Cell Culture, Immunofluorescence, and Genetics.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial